Lv4
616 积分 2025-11-24 加入
CMD-OPT model enables the discovery of a potent and selective RIPK2 inhibitor as preclinical candidate for the treatment of acute liver injury
10天前
已完结
Artificial intelligence in preclinical research: enhancing digital twins and organ-on-chip to reduce animal testing
17天前
已完结
Future Directions for Quantitative Systems Pharmacology
17天前
已完结
Emerging Approaches in Data-Driven Drug Discovery for Rare Diseases
17天前
已完结
Digital twin approaches for interpretable side effect prediction in drug discovery
17天前
已完结
Bioinformatics Paradigms in Drug Discovery and Drug Development
25天前
已完结
Advances in high-throughput drug screening based on pharmacotranscriptomics
26天前
已完结
Is Target-Based Drug Discovery Efficient? Discovery and “Off-Target” Mechanisms of All Drugs
26天前
已完结
HDAC-targeting epigenetic modulators for cancer immunotherapy
28天前
已完结
Pharmacological mechanisms of carvacrol against hepatocellular carcinoma by network pharmacology and molecular docking
1个月前
已完结
皖公网安备34019202002308
